轩竹生物-B：上半年亏损7530万元同比收窄32.1%

财中社08-26

8月26日，轩竹生物-B（02575）发布2026年中期业绩，公司收入约为6940万元，同比增加约288.1%，收入增长主要因新产品上市及纳入国家基本医保药品目录而带动销量增长；公司经营开支约为9340万元，同比减少约22.2%；公司亏损7530万元，同比收窄约32.1%。　　在财务回顾中，公司销售成本大幅增加603.9%至5410万元，主要因安久卫的销售增长和新增产品的上市销售带来的成本增加。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2662938760?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-26 13:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662938760","market":"sh","top_or_hot":-1,"title":"轩竹生物-B：上半年亏损7530万元 同比收窄32.1%","media":"财中社","content":"<div>\n<p>8月26日，轩竹生物-B（02575）发布2026年中期业绩，公司收入约为6940万元，同比增加约288.1%，收入增长主要因新产品上市及纳入国家基本医保药品目录而带动销量增长；公司经营开支约为9340万元，同比减少约22.2%；公司亏损7530万元，同比收窄约32.1%。　　在财务回顾中，公司销售成本大幅增加603.9%至5410万元，主要因安久卫的销售增长和新增产品的上市销售带来的成本增加。...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202608263854446117.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>轩竹生物-B：上半年亏损7530万元 同比收窄32.1%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n轩竹生物-B：上半年亏损7530万元 同比收窄32.1%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-26 13:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202608263854446117.html><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月26日，轩竹生物-B（02575）发布2026年中期业绩，公司收入约为6940万元，同比增加约288.1%，收入增长主要因新产品上市及纳入国家基本医保药品目录而带动销量增长；公司经营开支约为9340万元，同比减少约22.2%；公司亏损7530万元，同比收窄约32.1%。　　在财务回顾中，公司销售成本大幅增加603.9%至5410万元，主要因安久卫的销售增长和新增产品的上市销售带来的成本增加。...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202608263854446117.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02575","symbol_name":"轩竹生物-B","start_time":0,"source_url":"http://finance.eastmoney.com/a/202608263854446117.html","article_id":"2662938760","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608263854446117.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662938760","pubTimestamp":1787723460,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"8月26日，轩竹生物-B（02575）发布2026年中期业绩，公司收入约为6940万元，同比增加约288.1%，收入增长主要因新产品上市及纳入国家基本医保药品目录而带动销量增长；公司经营开支约为9340万元，同比减少约22.2%；公司亏损7530万元，同比收窄约32.1%。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02575":"轩竹生物-B","BK1191":"制药"},"translate_title":"Xuanzhu Bio-B: Loss of 75.3 million yuan in the first half of the year narrowed by 32.1% year-on-year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02575":1.5},"content_text":"8月26日，轩竹生物-B（02575）发布2026年中期业绩，公司收入约为6940万元，同比增加约288.1%，收入增长主要因新产品上市及纳入国家基本医保药品目录而带动销量增长；公司经营开支约为9340万元，同比减少约22.2%；公司亏损7530万元，同比收窄约32.1%。　　在财务回顾中，公司销售成本大幅增加603.9%至5410万元，主要因安久卫的销售增长和新增产品的上市销售带来的成本增加。毛利方面，尽管毛利增加至1530万元，但毛利率下降至22.1%，主要因新产品价格调整。公司研发开支同比减少67.1%至2750万元，主要由于核心产品的上市后研发支出大幅减少。　　公司的业务主要集中在药品销售，且新产品的上市及市场拓展对收入增长起到了重要作用。整体来看，公司的商业化进程和市场覆盖能力正在逐步提升，为未来的持续增长奠定了基础。（文章来源：财中社）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2662938760","isCrawlerRequest":true}

轩竹生物-B：上半年亏损7530万元 同比收窄32.1%

精彩评论

轩竹生物-B：上半年亏损7530万元同比收窄32.1%